Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.34M Sell
77,619
-1,234
-2% -$142K 0.2% 93
2025
Q4
$8.3M Buy
78,853
+887
+1% +$83.3K 0.18% 114
2025
Q3
$6.8M Sell
77,966
-4,538
-6% -$374K 0.15% 142
2025
Q2
$6.99M Sell
82,504
-2,533
-3% -$201K 0.17% 120
2025
Q1
$7.04M Sell
85,037
-310
-0.4% -$28.9K 0.2% 97
2024
Q4
$8.59M Sell
85,347
-1,476
-2% -$152K 0.25% 72
2024
Q3
$9.19M Sell
86,823
-1,745
-2% -$207K 0.27% 66
2024
Q2
$11.3M Buy
88,568
+422
+0.5% +$54.4K 0.34% 49
2024
Q1
$11.6M Buy
88,146
+2,857
+3% +$352K 0.37% 41
2023
Q4
$9.3M Sell
85,289
-505
-0.6% -$52.4K 0.32% 52
2023
Q3
$8.83M Sell
85,794
-964
-1% -$104K 0.34% 48
2023
Q2
$10M Buy
86,758
+1,977
+2% +$224K 0.38% 40
2023
Q1
$9.02M Sell
84,781
-238
-0.3% -$25.7K 0.37% 41
2022
Q4
$9.43M Sell
85,019
-385
-0.5% -$39.4K 0.42% 35
2022
Q3
$7.36M Buy
85,404
+8,472
+11% +$756K 0.38% 48
2022
Q2
$7.01M Sell
76,932
-564
-0.7% -$50K 0.46% 37
2022
Q1
$6.36M Buy
77,496
+49
+0.1% +$3.86K 0.36% 56
2021
Q4
$5.94M Buy
77,447
+5,566
+8% +$443K 0.31% 66
2021
Q3
$5.4M Buy
71,881
+6,263
+10% +$476K 0.32% 65
2021
Q2
$5.1M Buy
65,618
+1,371
+2% +$102K 0.3% 74
2021
Q1
$4.73M Buy
64,247
+3,262
+5% +$241K 0.32% 72
2020
Q4
$4.76M Buy
60,985
+2,602
+4% +$199K 0.35% 58
2020
Q3
$4.62M Buy
58,383
+9,243
+19% +$724K 0.4% 54
2020
Q2
$3.63M Buy
49,140
+10,471
+27% +$788K 0.36% 62
2020
Q1
$2.84M Sell
38,669
-2,257
-6% -$177K 0.39% 55
2019
Q4
$3.55M Buy
40,926
+1,289
+3% +$106K 0.38% 54
2019
Q3
$3.18M Sell
39,637
-6,022
-13% -$483K 0.42% 51
2019
Q2
$3.65M Buy
45,659
+8,658
+23% +$663K 0.47% 39
2019
Q1
$2.94M Sell
37,001
-463
-1% -$34.6K 0.43% 45
2018
Q4
$2.73M Buy
37,464
+179
+0.5% +$12.6K 0.54% 32
2018
Q3
$2.52M Buy
37,285
+1,043
+3% +$66.4K 0.38% 54
2018
Q2
$2.1M Buy
36,242
+3,578
+11% +$202K 0.48% 47
2018
Q1
$1.7M Buy
32,664
+2,762
+9% +$149K 0.43% 47
2017
Q4
$1.6M Buy
+29,902
New +$1.66M 0.61% 40

Other funds holding MRK

Mutual Advisors's MRK Position: Q1 2026 in Review

Mutual Advisors reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $142K and leaving 77,619 shares worth $9.34M. The position accounts for 0.2% of the portfolio, ranked #93.

Mutual Advisors first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $11.6M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mutual Advisors held 77,619 shares of Merck worth $9.34M as of Q1 2026.
  • Mutual Advisors sold 1,234 Merck shares in Q1 2026, an estimated $142K.
  • Merck made up 0.2% of Mutual Advisors's portfolio in Q1 2026, its #93 holding.
  • Mutual Advisors first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • Mutual Advisors's Merck position peaked at $11.6M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.